Literature DB >> 16374517

Inactivation of focal adhesion kinase in cardiomyocytes promotes eccentric cardiac hypertrophy and fibrosis in mice.

Xu Peng1, Marc S Kraus, Huijun Wei, Tang-Long Shen, Romain Pariaut, Ana Alcaraz, Guangju Ji, Lihong Cheng, Qinglin Yang, Michael I Kotlikoff, Ju Chen, Kenneth Chien, Hua Gu, Jun-Lin Guan.   

Abstract

Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase that plays a major role in integrin signaling pathways. Although cardiovascular defects were observed in FAK total KO mice, the embryonic lethality prevented investigation of FAK function in the hearts of adult animals. To circumvent these problems, we created mice in which FAK is selectively inactivated in cardiomyocytes (CFKO mice). We found that CFKO mice develop eccentric cardiac hypertrophy (normal LV wall thickness and increased left chamber dimension) upon stimulation with angiotensin II or pressure overload by transverse aortic constriction as measured by echocardiography. We also found increased heart/body weight ratios, elevated markers of cardiac hypertrophy, multifocal interstitial fibrosis, and increased collagen I and VI expression in CFKO mice compared with control littermates. Spontaneous cardiac chamber dilation and increased expression of hypertrophy markers were found in the older CFKO mice. Analysis of cardiomyocytes isolated from CFKO mice showed increased length but not width. The myocardium of CFKO mice exhibited disorganized myofibrils with increased nonmyofibrillar space filled with swelled mitochondria. Last, decreased tyrosine phosphorylation of FAK substrates p130Cas and paxillin were observed in CFKO mice compared with the control littermates. Together, these results provide strong evidence for a role of FAK in the regulation of heart hypertrophy in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16374517      PMCID: PMC1319217          DOI: 10.1172/JCI24497

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  67 in total

Review 1.  Stress pathways and heart failure.

Authors:  K R Chien
Journal:  Cell       Date:  1999-09-03       Impact factor: 41.582

Review 2.  Signaling pathways for cardiac hypertrophy and failure.

Authors:  J J Hunter; K R Chien
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

Review 3.  Cardiac mechanotransduction and implications for heart disease.

Authors:  Ralph Knöll; Masahiko Hoshijima; Kenneth Chien
Journal:  J Mol Med (Berl)       Date:  2003-10-09       Impact factor: 4.599

4.  Fibroblast growth factor-2 mediates pressure-induced hypertrophic response.

Authors:  J E Schultz; S A Witt; M L Nieman; P J Reiser; S J Engle; M Zhou; S A Pawlowski; J N Lorenz; T R Kimball; T Doetschman
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

5.  Heterozygous inactivation of the vinculin gene predisposes to stress-induced cardiomyopathy.

Authors:  Alice E Zemljic-Harpf; Sornya Ponrartana; Roy T Avalos; Maria C Jordan; Kenneth P Roos; Nancy D Dalton; Vinh Q Phan; Eileen D Adamson; Robert S Ross
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

Review 6.  Multiple connections link FAK to cell motility and invasion.

Authors:  David D Schlaepfer; Satyajit K Mitra
Journal:  Curr Opin Genet Dev       Date:  2004-02       Impact factor: 5.578

7.  Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block.

Authors:  Mohammad Pashmforoush; Jonathan T Lu; Hanying Chen; Tara St Amand; Richard Kondo; Sylvain Pradervand; Sylvia M Evans; Bob Clark; James R Feramisco; Wayne Giles; Siew Yen Ho; D Woodrow Benson; Michael Silberbach; Weinian Shou; Kenneth R Chien
Journal:  Cell       Date:  2004-04-30       Impact factor: 41.582

8.  Dilated cardiomyopathy caused by tissue-specific ablation of SC35 in the heart.

Authors:  Jian-Hua Ding; Xiangdong Xu; Dongmei Yang; Pao-Hsien Chu; Nancy D Dalton; Zhen Ye; Joanne M Yeakley; Heping Cheng; Rui-Ping Xiao; John Ross; Ju Chen; Xiang-Dong Fu
Journal:  EMBO J       Date:  2004-02-12       Impact factor: 11.598

9.  Restoration of resting sarcomere length after uniaxial static strain is regulated by protein kinase Cepsilon and focal adhesion kinase.

Authors:  Haytham Mansour; Pieter P de Tombe; Allen M Samarel; Brenda Russell
Journal:  Circ Res       Date:  2004-02-12       Impact factor: 17.367

10.  Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning.

Authors:  Robert M Smith; Naushaad Suleman; Lydia Lacerda; Lionel H Opie; Shizuo Akira; Kenneth R Chien; Michael N Sack
Journal:  Cardiovasc Res       Date:  2004-09-01       Impact factor: 10.787

View more
  63 in total

1.  Serine-910 phosphorylation of focal adhesion kinase is critical for sarcomere reorganization in cardiomyocyte hypertrophy.

Authors:  Miensheng Chu; Rekha Iyengar; Yevgeniya E Koshman; Taehoon Kim; Brenda Russell; Jody L Martin; Alain L Heroux; Seth L Robia; Allen M Samarel
Journal:  Cardiovasc Res       Date:  2011-09-21       Impact factor: 10.787

2.  Evidence for calreticulin attenuation of cardiac hypertrophy induced by pressure overload and soluble agonists.

Authors:  Sylvia Papp; Ewa Dziak; Golam Kabir; Peter Backx; Sophie Clement; Michal Opas
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

3.  B-type natriuretic peptide and extracellular matrix protein interactions in human cardiac fibroblasts.

Authors:  Brenda K Huntley; Tomoko Ichiki; S Jeson Sangaralingham; Horng H Chen; John C Burnett
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

Review 4.  Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes.

Authors:  Thomas Force; Kyle L Kolaja
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

5.  Chymase inhibition prevents fibronectin and myofibrillar loss and improves cardiomyocyte function and LV torsion angle in dogs with isolated mitral regurgitation.

Authors:  Betty Pat; Yuanwen Chen; Cheryl Killingsworth; James D Gladden; Ke Shi; Junying Zheng; Pamela C Powell; Greg Walcott; Mustafa I Ahmed; Himanshu Gupta; Ravi Desai; Chih-Chang Wei; Naoki Hase; Tsunefumi Kobayashi; Abdelkarim Sabri; Henk Granzier; Thomas Denney; Michael Tillson; A Ray Dillon; Ahsan Husain; Louis J Dell'italia
Journal:  Circulation       Date:  2010-09-27       Impact factor: 29.690

Review 6.  The (dys)functional extracellular matrix.

Authors:  Benjamin R Freedman; Nathan D Bade; Corinne N Riggin; Sijia Zhang; Philip G Haines; Katy L Ong; Paul A Janmey
Journal:  Biochim Biophys Acta       Date:  2015-04-27

7.  Gene expression patterns in transgenic mouse models of hypertrophic cardiomyopathy caused by mutations in myosin regulatory light chain.

Authors:  Wenrui Huang; Katarzyna Kazmierczak; Zhiqun Zhou; Vanessa Aguiar-Pulido; Giri Narasimhan; Danuta Szczesna-Cordary
Journal:  Arch Biochem Biophys       Date:  2016-02-22       Impact factor: 4.013

Review 8.  The role of Neuregulin-1beta/ErbB signaling in the heart.

Authors:  Laura Pentassuglia; Douglas B Sawyer
Journal:  Exp Cell Res       Date:  2008-09-03       Impact factor: 3.905

Review 9.  Vinculin and talin: focus on the myocardium.

Authors:  Alice Zemljic-Harpf; Ana Maria Manso; Robert S Ross
Journal:  J Investig Med       Date:  2009-12       Impact factor: 2.895

10.  Focal adhesion kinase as a RhoA-activable signaling scaffold mediating Akt activation and cardiomyocyte protection.

Authors:  Dominic P Del Re; Shigeki Miyamoto; Joan Heller Brown
Journal:  J Biol Chem       Date:  2008-10-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.